Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) safety market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Canine Arthritis Treatment Market between 2026 and 2030?

The canine arthritis treatment market has experienced robust growth recently. This market is projected to expand from $2.47 billion in 2025 to $2.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, this expansion has been driven by factors such as the increasing occurrence of canine arthritis, heightened awareness among pet owners, progress in veterinary pharmaceutical products, a growing dog population, and the proliferation of veterinary clinics and hospitals.

The market size for canine arthritis treatment is predicted to show consistent growth over the next few years, reaching $3.13 billion by 2030 with a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period is driven by factors such as the development of targeted biologic therapies, increased integration of precision medicine in veterinary practices, advancements in surgical techniques for joint repair, the expansion of online and retail veterinary pharmacies, and greater investment in stem cell and PRP research. Key trends expected in the forecast period include the increasing adoption of non-steroidal anti-inflammatory drugs (NSAIDs), a rise in the utilization of joint supplements like glucosamine and chondroitin, the growth of both stem cell therapy and platelet-rich plasma (PRP) treatments, an expansion of minimally invasive surgical procedures for dogs, and the integration of physical therapy and cold laser therapy into arthritis management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Canine Arthritis Treatment Market?

An anticipated increase in pet ownership is projected to drive expansion within the canine arthritis treatment market. Pet ownership encompasses the accountability and nurture exhibited by individuals or families when attending to the requirements, welfare, and companionship of domesticated animals primarily kept for enjoyment rather than practical use. This upward trend in pet ownership is attributable to various elements, including evolving lifestyles, the increasing humanization of companion animals, and enhanced disposable incomes. Owners utilize treatments for canine arthritis to manage and mitigate arthritic symptoms in their dogs, with the objective of enhancing their pets’ overall quality of life and preserving their ability to move. A notable example cited in April 2025 by the Canadian Animal Health Institute, a Canada-based trade association, revealed that in 2024, Canada harbored an estimated 7.2 million dogs and 8.2 million cats, signifying that pets constitute an essential component of more than half of Canadian households. Consequently, the increasing rate of pet ownership is serving as a catalyst for the expansion of the canine arthritis treatment market.

How Is The Canine Arthritis Treatment Market Organized Into Various Segments?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What Trends Are Expected To Impact The Competitive Landscape Of The Canine Arthritis Treatment Market?

Leading companies operating in the canine arthritis treatment market are introducing innovative therapies, such as bedinvetmab injections, to enhance canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection designed to target and neutralize nerve growth factor (NGF), a protein associated with pain, commonly employed in veterinary medicine. For example, in May 2023, Zoetis Inc., a US-based animal health company, secured approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. This product marks the first monoclonal antibody (mAb) approved by the FDA for use in dogs, functioning by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which plays a role in regulating pain linked to OA. Administered once a month via subcutaneous injection, it offers a convenient and enduring option for managing canine OA pain.

Who Are The Major Companies Operating In The Canine Arthritis Treatment Market?

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Canine Arthritis Treatment Market?

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Canine Arthritis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2026, By The Business Research Company

Companion Animal Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Veterinary Orthopedic Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Veterinary Pain Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company